$TENX Dr. Stuart Rich is one of the most respected PH experts out there.
He literally wrote a key JACC paper on using the 6MWD as a primary endpoint in PH trials, served on the FDA Cardiovascular Advisory Committee for years
Having him as CMO is pretty reassuring imo
If $TENX had used daily oral levosimendan in Phase 2, they very likely would have hit the primary endpoint
Acute 24h IV showed strong exercise PCWP drop + 84% responders
The miss only happened because they measured at trough